23 phd-computer-science-"IMPRS-ML"-"IMPRS-ML" research jobs at University of Newcastle
Sort by
Refine Your Search
-
projects. The role will also provide the opportunity to learn and develop medicinal chemistry skills as applied to drug design. The role is ideal for someone who has, or is about to be awarded, a PhD in
-
, especially those with expertise in human beta-cell/islet culture. This post is fixed term for a period of 12 Months. If you have any queries, please reach out to Catherine.Arden@newcastle.ac.uk or Bill.Scott3
-
research aligned with the Materials, Concepts and Reaction Engineering Group [1]. As this position will be funded by a specific research grant [2], you must have experience in laboratory experiments with ion
-
for Research Associate • PhD in any related areas, preferable in an interdisciplinary topic (e.g. Computational Neuroscience, or Biomedical Engineering) Newcastle University is a global University where
-
in a relevant subject e.g. Engineering, Maths, Computer Science Newcastle University is a global University where everyone is treated with dignity and respect. As a University of Sanctuary, we aim
-
recently refurbished, state-of-the-art chemical biology laboratories at Newcastle University. The role may involve supporting the supervision and training of PhD students. Strong time management skills
-
Research Assistant/Associate to undertake work as part of our NU Solve programme. Newcastle University Solve (NU Solve) in the School of Mathematics, Statistics & Physics (MSP) has a track record of
-
and Language Sciences, including our Speech and Language Sciences subject area. The postholder should have a PhD in a relevant discipline e.g. Speech and Language Sciences, Education, Psychology
-
. The role will also provide the opportunity to learn and develop skills in structure-based drug design. The role is ideal for someone who has, or is about to be awarded, a PhD in structural biology and would
-
work on the INSTINCT-MB programme, which brings together teams based at Newcastle University, The Institute of Cancer Research and University College London. The programme will generate a wide range of